Isomorphic Labs breaks biotech VC fundraising record with $5B series C
After securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.
Isomorphic Labs is an AI-first drug design company spun out of Google DeepMind and backed by Alphabet. It applies the protein-structure modelling lineage behind AlphaFold to design small-molecule and biologic candidates, combining internal programmes with research partnerships across large pharma.
After securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.
Co-Founder and Chief Executive Officer